← Eichor
Study identifier: NCT05460780 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

First-in-human, Study of MATTISSE® Tissue Engineering Chamber in Adult Female Patients Undergoing Breast Reconstruction After Mastectomy for Cancer

Condition: Breast Cancer Female · Breast Cancer Prevent · Breast Reconstruction  ·  Sponsor: Quanta Medical

PhaseNA
Planned participants50
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study is a first in human, two-stage single arm non-comparative study of safety and performance. The aim of the study is to asses the safety and the clinical performance of a new device : the MATTISSE tissu engineering chamber.

This description comes directly from the study's public registry record.

Talk to the study team

Pierre GUERRESCHI, Pr  ·  03.20.44.56.59  ·  clinic@lattice-medical.com

Always discuss trial participation with your own doctor first.

Locations (3)

CHU de StrasbourgStrasbourg, France, FranceRecruiting
Hospital of LilleLille, Nord, FranceRecruiting
Institute of Clinical OncologyTbilisi, GeorgiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05460780